NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球胎牛血清市場:2020-2026

Global Fetal Bovine Serum Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008070
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球胎牛血清市場:2020-2026 Global Fetal Bovine Serum Market 2020-2026
出版日期: 2021年04月19日內容資訊: 英文
簡介

在預測期內,全球胎牛血清市場規模預計將以顯著的複合年增長率增長。胎牛血清 (FBS) 是胎牛凝固血的液體部分,不含細胞、纖維蛋白和凝血因子,但含有許多細胞生長所必需的營養因子和高分子,含有分子因子。牛血清白蛋白是FBS的主要成分。 FBS 生長因子對於培養細胞的維持和生長至關重要。 FBS還含有多種小分子,如氨基酸、醣類、脂類和激素。

從基礎研究到專業化驗,藥物發現和研發中對胎牛血清的廣泛需求推動了市場增長。此外,其對細胞培養作為理想細胞增殖補充劑的巨大需求以及對其他類型細胞培養血清的日益偏愛也推動了市場增長。市場上銷售各種等級的胎牛血清,包括標準和特殊等級,具體取決於應用。新藥研發活動的增加、生物製藥行業的擴張以及政府投資和資金的增加也在胎牛血清市場的增長中發揮了關鍵作用。

然而,與生物技術研究實踐的潛在濫用和缺乏熟練人員相關的倫理和科學問題正在阻礙胎牛血清市場。私營部門和政府部門在研發活動和新藥開發方面的快速進展有望為全球胎牛血清市場提供有利的增長機會。

本報告調查了全球胎牛血清市場,按產品類型、最終用戶、應用、地區和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢
  • 規則

第 3 章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
    • 近期發展
  • 主要戰略分析

第 4 章市場決定因素

  • 動力
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 按產品類型劃分的全球胎牛血清市場
    • 木炭條
    • 色譜儀
    • 透析 FBS
    • 幹細胞
    • 其他(外泌體耗竭)
  • 按最終用戶劃分的全球胎牛血清市場
    • 生物製品和製藥公司
    • 調查
    • 學術機構
    • 其他(細胞庫)
  • 按應用分列的全球胎牛血清市場
    • 產業研究
    • 科學研究

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東盟
    • 其他
  • 其他領域
    • 拉丁美洲
    • 中東 非洲

第 7 章公司簡介

  • Access Biologicals LLC
  • Animal Technologies, Inc.
  • Atlanta Biologicals(R&D Systems, Inc.)
  • Axil Scientific Pte Ltd
  • Biological Industries Ltd.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Corning Inc.
  • Cytiva
  • ExCell Biotech Co., Ltd.
  • General Electric Co.
  • HiMedia Laboratories
  • Life Technologies(India)Pvt Ltd
  • Merck KGaA
  • Moregate Biotech
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • Rocky Mountain Biologicals, Inc.
  • Thermo Fisher Scientific Inc.
  • Tissue Culture Biologicals
  • TCS Biosciences Ltd.
目錄
Product Code: OMR2023363

Global Fetal Bovine Serum Market Size, Share & Trends Analysis Report by Product Type (Charcoal Stripped, Chromatographic, Dialyzed FBS, Stem Cell, and Others) By End-User (Bioproduct & Pharmaceutical Companies, Research Laboratories, Academic Institutes, and Others) By Application (Industrial Research and Research and Scientific Research) Forecast 2021-2027

The global market for fetal bovine serum is projected to have a considerable CAGR during the forecast period. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin, and clotting factors, but containing a large number of nutritional and macro-molecular factors essential for cell growth. Bovine serum albumin is the major component of FBS. Growth factors in FBS are essential for the maintenance and growth of cultured cells. FBS also contains a variety of small molecules such as amino acids, sugars, lipids, and hormones.

The market growth is driven by extensive demand for fetal bovine serum in drug discovery and R&D, from basic research to specialty assays. Besides, its significant demand in cell culture as an ideal cell growth supplement and growing preference over other types of cell culture sera is also fueling the growth of the market. There are a variety of fetal bovine serum grades including standard and specialty grades available in the market based on application. The increasing R&D activities for novel drugs, expansion of bio-pharmaceutical industries, and increase in investment and funding from the government also play a significant role in the growth of the fetal bovine serum market.

However, the ethical and scientific concerns associated with the potential misuse of biotechnology research practices and the shortfall of skilled personnel hinder the fetal bovine serum market. The rapid advancement in R&D activities and new drug developments by private and government sectors are expected to offer lucrative growth opportunities in the global fetal bovine serum market.

Segmental Outlook

The global Fetal Bovine Serum market is segmented into product type and end-user. On the basis of product type, the market is sub-segmented into charcoal-stripped, chromatographic, dialyzed FBS, stem cell, and others. Among these, the stem cell segment is expected to grow significantly owing to the adoption of these stem cells in various animal cell cultures. Based on end-user, the market is classified into bioproduct & pharmaceutical companies, research laboratories, academic institutes, and others. Similarly, by application, the fetal bovine serum market is categorized into industrial research and scientific research.

Global Fetal Bovine Serum Market Share by Application, 2020(%)

Source: OMR global

The Cell Culture Maintenance Sub-Segment dominated the Fetal Bovine Serum Market.

Among, application, the cell culture maintenance sub-segment in scientific research held the major market share in 2020, and it is also expected to maintain its dominance in terms of growth during the forecast period. It is most widely used as a supplement during cell culture media exceeds cell culture testing standards to identify growth factors responsible for cultured cells. Thus, the use of fetal bovine serum in cell culture due to its high quantity of hormones, carrier proteins, and macro-molecular proteins to promote growth medium will lead to the growth of this segment which, in turn, further drives the market growth.

Regional Outlook

Geographically, the global Fetal Bovine Serum market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)).

Asia-Pacific is anticipated to grow at the highest CAGR owing to the growing demand for advanced healthcare facilities in emerging economies of the region. Additionally, the increasing focus of major market players towards the development of innovative products by collaborating with other market players in the region further provide ample opportunity to market.

Moreover, the increasing interest of the government and regulatory bodies towards stem cell research and development activities in emerging economies such as India and China are some other factors that are contributing to the growth of the fetal bovine serum market in Asia-Pacific. Apart from this, the infrastructural development and rise in outsourcing of research activities to the contract research organizations (CRO) coupled with low-cost fuels the market growth.

Global Fetal Bovine Serum Market Growth by Region, 2021-2027

Source: OMR Global

North America held the major market share in the Fetal Bovine Serum market

Geographically, North America dominated the fetal bovine serum market in 2020, and is expected to grow continuously during the forecast period. The factors that drive the growth of the fetal bovine serum market in the region include the growing awareness about fetal bovine serums among the population and rising funding for R&D activities. North America has a well-developed healthcare infrastructure, owing to which, the companies invest largely in the development of an innovative platform for cell culture systems. North America is the largest market for manufacturing bio-pharmaceutical and laboratory products, hence create enormous opportunities for the fetal bovine serum market that drives the market in the region.

Market Players Outlook

Some of the key players in the fetal bovine serum market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market are Thermo Fisher Scientific Inc, General Electric, Merck KGaA, PAN-Biotech GmbH, HiMedia Laboratories, TCS Biosciences Ltd., Corning Inc., among others. To survive in the market, these market players adopt different marketing strategies such as mergers & acquisitions, R&D, product launches, and geographical expansions so on. For instance, in January 2019, Bio-Tech Corp., acquired Atlanta Biologicals based in Georgia specialized in the making of bovine-derived serum that promotes cell growth during the biotech experiment. With this acquisition, Bio-Tech Corp. has expanded its product portfolio in tissue-culture reagents with cell culture and tissue regeneration capabilities of Atlanta Biologicals in fetal bovine serum.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Fetal Bovine Serum market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Fetal Bovine Serum Market By Product Type
    • 5.1.1. Charcoal Stripped
    • 5.1.2. Chromatographic
    • 5.1.3. Dialyzed FBS
    • 5.1.4. Stem Cell
    • 5.1.5. Others (Exosome Depleted)
  • 5.2. Global Fetal Bovine Serum Market By End-User
    • 5.2.1. Bioproduct & Pharmaceutical Company
    • 5.2.2. Research Laboratory
    • 5.2.3. Academic Institute
    • 5.2.4. Others (Cell Bank)
  • 5.3. Global Fetal Bovine Serum Market, By Application
    • 5.3.1. Industrial Research
      • 5.3.1.1. Antibody Production
      • 5.3.1.2. Veterinary Applications
    • 5.3.2. Scientific Research
      • 5.3.2.1. Cell Culture Maintenance
      • 5.3.2.2. Exosome Research
      • 5.3.2.3. Immunoassays Methods

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korean
    • 6.3.5. ASEAN
    • 6.3.6. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East Africa

7. Company Profiles

  • 7.1. Access Biologicals LLC
  • 7.2. Animal Technologies, Inc.
  • 7.3. Atlanta Biologicals (R&D Systems, Inc.)
  • 7.4. Axil Scientific Pte Ltd
  • 7.5. Biological Industries Ltd.
  • 7.6. Biowest SAS
  • 7.7. Bovogen Biologicals Pty Ltd.
  • 7.8. Corning Inc.
  • 7.9. Cytiva
  • 7.10. ExCell Biotech Co., Ltd.
  • 7.11. General Electric Co.
  • 7.12. HiMedia Laboratories
  • 7.13. Life Technologies (India) Pvt Ltd
  • 7.14. Merck KGaA
  • 7.15. Moregate Biotech
  • 7.16. Nucleus Biologics
  • 7.17. PAN-Biotech GmbH
  • 7.18. Rocky Mountain Biologicals, Inc.
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. Tissue Culture Biologicals
  • 7.21. TCS Biosciences Ltd.

LIST OF TABLES

  • 1. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL CHARCOAL STRIPPED FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CHROMATOGRAPHIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL DIALYZED FBS FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL STEM CELL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL OTHERS FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 8. GLOBAL FETAL BOVINE SERUM FOR BIOPRODUCT & PHARMACEUTICAL COMPANY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL FETAL BOVINE SERUM FOR RESEARCH LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL FETAL BOVINE SERUM FOR ACADEMIC INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL FETAL BOVINE SERUM FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 13. GLOBAL FETAL BOVINE SERUM IN INDUSTRIAL RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL FETAL BOVINE SERUM IN SCIENTIFIC RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 20. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 23. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 26. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 28. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 3. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 4. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL CHARCOAL STRIPPED FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL CHROMATOGRAPHIC FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL DIALYZED FBS FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL STEM CELL FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL FETAL BOVINE SERUM FOR BIOPRODUCT & PHARMACEUTICAL COMPANY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL FETAL BOVINE SERUM FOR RESEARCH LABORATORY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL FETAL BOVINE SERUM FOR ACADEMIC INSTITUTE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL FETAL BOVINE SERUM FOR OTHERS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL FETAL BOVINE SERUM IN INDUSTRIAL RESEARCH MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL FETAL BOVINE SERUM IN SCIENTIFIC RESEARCH MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. US FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. CANADA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. UK FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. FRANCE FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. GERMANY FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. ITALY FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. SPAIN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF EUROPE FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. INDIA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CHINA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. JAPAN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. ASEAN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)